Heart Disease Clinical Trials in Baltimore

Showing 281-300 of 583 trials

Cuff(SZ): The Cuff Size Blood Pressure Measurement Trial

NCT04610775

To determine the impact of overcuffing (using a too-large cuff) and undercuffing (using a too-small cuff) on initial BP and average BP measurements when using an automated BP device, overall and stratified by appropriate cuff size To determine if the impact over- or under-cuffing differs based on the following patient characteristics: 1. Hypertensive (≥140/90 based on triplicate measures using appropriately sized cuff) vs. non-hypertensive. 2. Arm circumference (continuous) 3. Obesity status

HypertensionBlood PressureCardiovascular Diseases+1 more

Johns Hopkins University194 participantsStarted Mar 2021

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

NCT02929329

The purpose of this study is to determine if treatment with omecamtiv mecarbil when added to standard of care is well tolerated and superior to placebo in reducing the risk of cardiovascular death or heart failure events in adults with chronic heart failure with reduced ejection fraction (HFrEF).

Heart Failure

Cytokinetics8,256 participantsStarted Jan 2017

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +1030 more locations

Cuff(SZ): The Cuff Size Blood Pressure Measurement Trial

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Heart Disease Trials in Other Cities

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Improving Cardiovascular Treatment Approaches Among Minorities

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Myocardial Perfusion and Scarring in Congenital Heart Disease

Atherosclerotic Coronary Vulnerable Plaque: Correlation With Coronary Artery Calcium

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

A Study of CK-1827452 Infusion in Stable Heart Failure

Melatonin and Salt on Blood Vessel Function

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

The International Polycap Study 3 (TIPS-3)

Other Conditions in Baltimore